Neurocritical care · 2008
Concurrent neurocysticercosis and pulmonary tuberculosis.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Miller Chad M, Vespa Paul M
Аннотация
OBJECTIVE: We discuss the case of a 24-year-old male with severe racemose neurocysticercosis.
CLINICAL FEATURES: The patient presented from an outside hospital with 4 months duration of intermittent syncope and a dull occipital headache with greatest severity in the morning. He was noted to have left facial numbness and blurred vision confined to his left eye. Magnetic resonance imaging (MRI) discovered multiple grape-like cystic structures throughout the subarachnoid space and frontal parenchyma consistent with neurocysticercosis. Additional testing revealed radiologic and culture evidence of active pulmonary tuberculosis.
INTERVENTIONS AND OUTCOME: The patient was admitted to the neurocritical care unit and begun on IV corticosteroids, albendazole, and 4-drug RIPE therapy. Improvement in headache, facial numbness, and nausea were noted over the course of 1 week. Visual acuity remained impaired; however, no further episodes of syncope or deterioration were noted.
CONCLUSION: Effective management of severe racemose neurocysticercosis requires appropriate diagnostic considerations, monitoring, and therapeutics well suited to a comprehensive neurocritical care unit.
CLINICAL FEATURES: The patient presented from an outside hospital with 4 months duration of intermittent syncope and a dull occipital headache with greatest severity in the morning. He was noted to have left facial numbness and blurred vision confined to his left eye. Magnetic resonance imaging (MRI) discovered multiple grape-like cystic structures throughout the subarachnoid space and frontal parenchyma consistent with neurocysticercosis. Additional testing revealed radiologic and culture evidence of active pulmonary tuberculosis.
INTERVENTIONS AND OUTCOME: The patient was admitted to the neurocritical care unit and begun on IV corticosteroids, albendazole, and 4-drug RIPE therapy. Improvement in headache, facial numbness, and nausea were noted over the course of 1 week. Visual acuity remained impaired; however, no further episodes of syncope or deterioration were noted.
CONCLUSION: Effective management of severe racemose neurocysticercosis requires appropriate diagnostic considerations, monitoring, and therapeutics well suited to a comprehensive neurocritical care unit.